Henry Schein (HSIC) Tops Q2 EPS by 3c, Revenues Beat; Increases FY18 EPS Outlook
Henry Schein (NASDAQ: HSIC) reported Q2 EPS of $1.04, $0.03 better than the analyst estimate of $1.01. Revenue for the quarter came in at $3.33 billion versus the consensus estimate of $3.31 billion.
"Results for the second quarter reflect solid revenue growth in generally healthy end-markets, as well as our continued success in gaining market share in all of our business groups. We are in the early stages of executing on our new strategic plan for 2018 through 2020, yet we are already making solid strides in expanding our offering of innovative solutions and extending our value proposition for customers," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein.
Henry Schein, Inc. today is revising its 2018 non-GAAP diluted EPS guidance. At this time the Company is not able to provide estimates for the total impact of costs related to the Animal Health spin-off on full year 2018 financial results. Guidance is as follows:
- 2018 non-GAAP diluted EPS attributable to Henry Schein, Inc. is now expected to be $4.06 to $4.14, reflecting growth of 13% to 15% compared with 2017 non-GAAP diluted EPS of $3.60, versus prior guidance of $4.03 to $4.14. This guidance includes costs related to a previously announced one-time cash bonus to certain designated staff members and excludes costs related to the restructuring and the planned spin-off of the Henry Schein Animal Health business in 2018. 2017 non-GAAP results exclude costs related to taxes associated with U.S. tax reform legislation, a loss associated with Henry Schein\'s divestiture of its equity ownership in E4D Technologies and litigation settlement expenses in 2017.
- Guidance for 2018 non-GAAP diluted EPS attributable to Henry Schein, Inc. is for current continuing operations as well as completed or previously announced acquisitions, and does not include the impact of potential future acquisitions, if any. Henry Schein expects to update full-year earnings guidance for the remaining business once the spin-off of its Animal Health business closes. Guidance also assumes foreign exchange rates that are generally consistent with current levels.
GUIDANCE:
Henry Schein sees FY2018 EPS of $4.06-$4.14, versus the consensus of $4.10.
For earnings history and earnings-related data on Henry Schein (HSIC) click here.
